Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats

Kidney and Blood Pressure Research

Volumn 20, Issue 4, 1997, Pages 211-217

  Waz, Wayne R ^a   Van Liew, Judith B ^a   Feld, Leonard G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aminoguanidine; Kidney; Nitric oxide; Nitric oxide synthase; Renal function

Indexed keywords

4 AMINOHIPPURIC ACID; AMINOGUANIDINE; ARGININE METHYL ESTER; INULIN; NITRIC OXIDE; SODIUM;

4 AMINOHIPPURIC ACID CLEARANCE; ANIMAL EXPERIMENT; ARTICLE; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION;

EID: 0030662941     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000174148     Document Type: Article

References (35)

1. Bachmann S, Mundel P: Nitric oxide and the kidney: Synthesis, localization, and function. Am J Kidney Dis 1994:24:112-129.
2. Walder CE. Thiemermann C. Vane JR: The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1992:102:967-973.
3. Mattson DL. Roman RJ. Cowley AW: Role of nitric oxide in renal papillary blood How and sodium excretion. Hypertension 1992:19:766-769.
4. Baylis C. Mitruka B. Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-281.
5. Deng A. Baylis C: Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 1993:33: F2I2-F215.
6. Stoos BA. Carretero OA. Farhy RD, Scicli G. Garvin JL: Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells. J Clin Invest 1992;89:761-765.
7. Wilcox CS. Welch MJ. Murad F. Gross SS. Taylor G, Levi R. Schmidt HHHW: Nitric oxide synthase in macula densa regulates glomerular capillary' pressure. Proc Natl Acad Sci USA 1992:89:11993-11997.
8. Bank N. Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993;43:1306-1312.
9. Mathis KM. Banks RO: Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration. J Am Soc Nephrol 1996:7:105-112.
10. Cook HT. Jansen A. Lewis S. Largcn P. O’Donnell M. Reaveley D, Cattell V: Arginine metabolism in experimental glomerulonephritis: Interaction between nitric oxide synthase and ar-ginase. AmJ Physiol 1994;267:F646-F653.
11. Fukuto JM. Mayer B: The cnzymology of nitric oxide synthase; in Feelisch M. Stamler S (eds): Methods in Nitric Oxide Research. New York. Wiley, 1996, pp 147-160.
12. Mundel P. Bachman S, Bader M. Fischer A. Kummer W. Mayer B. Kriz W: Expression of nitric oxide synthase in kidney macula densa cells. Kidney lnt 1992:42:1018-1019.
13. Terada Y. Tomita K. Nonoguchi H. Marumo F: Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble gua-nylate cyclase messenger RNAs in microdis-sected rat nephron segments. J Clin Invest 1992;90:659-665.
14. Morrissey JJ. McCracken R. Kaneto H. Vehas-kari M. Montani D. Klahr S: Location of an inducible nitric oxide synthase in tnRNA in the nomial kidney. Kidney Int 1994:45:998-1005.
15. Misko TP. Moore WM. Kasten TP, Nickols GA. Corbett JA. Tilton RG. McDaniel ML, Williamson JR, Currie MG: Selective inhibition of the inducible nitric oxide synthase by aminoguani-dinc. Eur J Pharmacol 1993:233:119-125.
16. Griffith OW, Gross S: Inhibitors of nitric oxide synthases; in Feelisch M. Stamler S (eds): Methods in Nitric Oxide Research. New York. Wiley. 1996. pp 187-208.
17. Kumari K. Lmar S. Bansal V, Sahib MK: Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes 1991:40: 1079-1084.
18. Nicholls K. Mandel TE:Advanced glycosyla-tion end products in experimental murine diabetic nephropathy: Effect of islet cell isograft-ing and of aminoguanidine. Lab Invest 1989: 60:486-491.
19. Ellis EN. Good BH: Prevention of glomerular basement membrane thickening by aminogua-nidinc in experimental diabetes mcllitus. Metabolism 1991:40:1016-1019.
20. Edelstein D. Brownlee M: Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetalogia 1992;35:96-97.
21. Itakura M. Yoshikawa H. Bannai C, Kato M, Kunika K. Kawakami Y, Yamaoka T, Yamashita K: Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats. Life Sci 1991:49:889-897.
22. Corbcti JA. Tilton RG. Chang K. Hasan KS. Ido Y. Wang JL, Sweetland MA. Lancaster JR. Williamson JR. McDaniel ML: Aminoguanidinc. a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992:41:552-556.
23. Tilton RG. Chang K. Hasan KS. Smith SR. Pe-trash JM. Misko TP. Moore WM. Currie MG, Corbett JA. McDaniel ML. Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993:42:221-232.
24. Feld LG. Van Liew JB.,: Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney lnt 1977:12:332 343.
25. Fuhr S. Kaczmarczyk J, Kruttgen CD: Eine einfache colorimetrische Methode zur Insulinbestimmung für Nierenclearanceuntersuchungen bei Stofiwechsclgesunden und Diabetikern. Klin Wochenschr 1955:33:729-730.
26. Smith HW. Finkelstein N. Alimonosa L, Crawford B, Grabcr M: The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945: 24:388-404.
27. Feld LG, Cachcro S. Ellis EN. Dedeoglu O, Ue-da Y. Leonard C. Letizia R. Mallon V, Van Liew JB: Resistance to glomerular injury in the diabetic BioBreeding rat. Exp Physiol 1995:80: 991-1000.
28. Schultz, PJ. Raij L: Ednogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992;90: 1818-1825.
29. Bucala R. Tracey KJ, Cerami A: Advanced gly-cosy lation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-438.
30. Baylis C. Harvey J. Engels K: Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin 11. J Am Soc Nephrol 1994: 5:211-214.
31. Thorup C. Erik A. Persson G: Macula densa derived nitric oxide in regulation of glomerular capillary pressure. Kidney lnt 1996:49:430-436.
32. McKillop I, Haylor J, cl Nahas. IGF-1 stimulates renal function in the isolated rat kidney: Inhibition by aminoguanidine and nitroargmine methyl ester. Exp Nephrol 1995;3:49-57.
33. Sonaka I, Futami Y. Maki T: a-Arginine-nitric oxide pathway and chronic nephropathy in aged rats. J Gerontol 1994:49:13157-161.
34. Li YM. Steffes M, Donnelly T. Liu C, Fuh H, Basgcn J. Bucala R. Vlassara H: Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA 1996:93:3902-3907.
35. Bucala R. Vlassara H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995:26:875-888